Human embryonic stem cells and gene therapy

Molecular Therapy

Volumn 15, Issue 5, 2007, Pages 850-866

  Strulovici, Yael ^a   Leopold, Philip L ^a   O'Connor, Timothy P ^a   Pergolizzi, Robert G ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTIBIOTIC AGENT; BETA GALACTOSIDASE; CYTOSINE DEAMINASE; DYSTROPHIN; ENHANCED GREEN FLUORESCENT PROTEIN; FLUCYTOSINE; GANCICLOVIR; LENTIVIRUS VECTOR; LIPOFECTAMINE; OLIGOPEPTIDE; PARVOVIRUS VECTOR; PHOSPHOGLYCERATE KINASE; PLASMID DNA; POLYMER; RETROVIRUS VECTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; VIRUS VECTOR;

CELL BASED GENE THERAPY; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CELL ISOLATION; CELL LINEAGE; CYSTIC FIBROSIS; CYTOMEGALOVIRUS; DNA MODIFICATION; DRUG MECHANISM; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENE EXPRESSION REGULATION; GENE INSERTION; GENETIC DISORDER; GENETIC ENGINEERING; GENETIC SCREENING; GENETIC TRANSFECTION; GRAFT VERSUS HOST REACTION; GROWTH REGULATION; HUMAN; MEDICAL RESEARCH; MUSCULAR DYSTROPHY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PLURIPOTENT STEM CELL; PROGENY; PROMOTER REGION; REPORTER GENE; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SKIN FIBROBLAST; STEM CELL TRANSPLANTATION; SUICIDE GENE THERAPY; TERATOMA; TRANSGENE; TREATMENT FAILURE; VIRAL GENE DELIVERY SYSTEM; VIRUS STRAIN; XENOGRAFT;

CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MODELS, BIOLOGICAL;

EID: 34247240377     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.sj.6300125     Document Type: Review

References (132)

1. Amit, M and Itskovitz-Eldor, J (2002). Derivation and spontaneous differentiation of human embryonic stem cells. J Anat 200: 225-232.
2. Carpenter, MK, Rosler, E and Rao, MS (2003). Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 5: 79-88.
3. Hoffman, LM and Carpenter, MK (2005). Characterization and culture of human embryonic stem cells. Nat Biotechnol 23: 699-708.
4. Martin, GR (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78: 7634-7638.
5. Moon, SY, Park, YB, Kim, DS, Oh, SK and Kim, DW (2006). Generation, culture, and differentiation of human embryonic stem cells for therapeutic applications. Mol Ther 13: 5-14.
6. Polak, JM and Bishop, AE (2006). Stem cells and tissue engineering: past, present, and future. Ann N Y Acad Sci 1068: 352-366.
7. Rodriguez, CI, Galan, A, Valbuena, D and Simon, C (2006). Derivation of clinical-grade human embryonic stem cells. Reprod Biomed Online 12: 112-118.
8. Skottman, H, Dilber, MS and Hovatta, O (2006). The derivation of clinical-grade human embryonic stem cell lines. FEBS Lett 580 2875-2878.
9. Thomson, JA, Itskovitz-Eldor, J, Shapiro, SS, Waknitz, MA, Swiergiel, JJ, Marshall, VS et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
10. Strelchenko, N, Verlinsky, O, Kukharenko, V and Verlinsky, Y (2004). Morula-derived human embryonic stem cells. Reprod Biomed Online 9: 623-629.
11. Zhang, X, Stojkovic, P, Przyborski, S, Cooke, M, Armstrong, L, Lako, M et al. (2006). Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells 24: 2669-2676.
12. Klimanskaya, I, Chung, Y, Becker, S, Lu, SJ and Lanza, R (2006). Human embryonic stem cell lines derived from single blastomeres. Nature 444: 481-485.
13. Ben-Nun, IF and Benvenisty, N (2006). Human embryonic stem cells as a cellular model for human disorders. Mol Cell Endocrinol 252: 154-159.
14. Fischbach, GD and Fischbach, RL (2004). Stem cells: Science, policy, and ethics. J Clin Invest 114: 1364-1370.
15. Evans, M (2005). Ethical sourcing of human embryonic stem cells - rational solutions? Nat Rev Mol Cell Biol 6: 663-667.
16. Murray, TH (2005). Ethical (and political) issues in research with human stem cells. Novartis Found Symp 265: 188-196.
17. Brock, DW (2006). Is a consensus possible on stem cell research? Moral and political obstacles. J Med Ethics 32: 36-42.
18. Schuldiner, M, Yanuka, O, Itskovitz-Eldor, J, Melton, DA and Benvenisty, N (2000). Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 97: 11307-11312.
19. O'Connor, TP and Crystal, RG (2006). Genetic medicines: Treatment strategies for hereditary disorders. Nat Rev Genet 7: 261-276.
20. Cibelli, JB, Cunniff, K and Vrana, KE (2006). Embryonic stem cells from parthenotes. Methods Enzymol 418: 117-135.
21. Denning, C and Priddle, H (2003). New frontiers in gene targeting and cloning: Success, application and challenges in domestic animals and human embryonic stem cells. Reproduction 126: 1-11.
22. Edwards, JL, Schrick, FN, McCracken, MD, van Amstel, SR, Hopkins, FM, Welborn, MG et al. (2003). Cloning adult farm animals: A review of the possibilities and problems associated with somatic cell nuclear transfer. Am J Reprod Immunol 50: 113-123.
23. Hochedlinger, K and Jaenisch, R (2006). Nuclear reprogramming and pluripotency. Nature 441: 1061-1067.
24. Jaenisch, R (2002). Nuclear cloning, embryonic stem cells, and transplantation therapy. Harvey Lect 98: 145-171.
25. Kim, K, Lerou, P, Yabuuchi, A, Lengerke, C, Ng, K, West, J et al. (2007). Histocompatible embryonic stem cells by parthenogenesis. Science 315: 482-486.
26. Mayhall, EA, Paffett-Lugassy, N and Zon, LI (2004). The clinical potential of stem cells. Curr Opin Cell Biol 16: 713-720.
27. Wells, DN (2005). Animal cloning: Problems and prospects. Rev Sci Tech 24: 251-264.
28. National Institutes of Health (2001). Information on eligibility criteria for federal funding of research on human embryonic stem cells. Stem Cell Information. .
29. Pickering, SJ, Braude, PR, Patel, M, Burns, CJ, Trussler, J, Bolton, V et al. (2003). Preimplantation genetic diagnosis as a novel source of embryos for stem cell research. Reprod Biomed Online 7: 353-364.
30. Verlinsky, Y, Strelchenko, N, Kukharenko, V, Rechitsky, S, Verlinsky, O, Galat, V et al. (2005). Human embryonic stem cell lines with genetic disorders. Reprod Biomed Online 10: 105-110.
31. Urbach, A, Schuldiner, M and Benvenisty, N (2004). Modeling for Lesich-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells 22: 635-641.
32. Zwaka, TP and Thomson, JA (2003). Homologous recombination in human embryonic stem cells. Nat Biotechnol 21: 319-321.
33. Eiges, R, Schuldiner, M, Drukker, M, Yanuka, O, Itskovitz-Eldor, J and Benvenisty, N (2001). Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol 11: 514-518.
34. Lebkowski, JS, Gold, J, Xu, C, Funk, W, Chiu, CP and Carpenter, MK (2001). Human embryonic stem cells: Culture, differentiation, and genetic modification for regenerative medicine applications. Cancer J 7 (suppl. 2): S83-S93.
35. Siemen, H, Nix, M, Endl, E, Koch, P, Itskovitz-Eldor, J and Brustle, O (2005). Nucleofection of human embryonic stem cells. Stem Cells Dev 14: 378-383.
36. Vallier, L, Rugg-Gunn, PJ, Bouhon, IA, Andersson, FK, Sadler, AJ and Pedersen, RA (2004). Enhancing and diminishing gene function in human embryonic stem cells. Stem Cells 22: 2-11.
37. Liu, YP, Dovzhenko, OV, Garthwaite, MA, Dambaeva, SV, Duming, M, Pollastrini, LM et al. (2004). Maintenance of pluripotency in human embryonic stem cells stably over-expressing enhanced green fluorescent protein. Stem Cells Dev 13: 636-645.
38. Gerrard, L, Zhao, D, Clark, AJ and Cui, W (2005). Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency. Stem Cells 23: 124-133.
39. Smith-Arica, JR, Thomson, AJ, Ansell, R, Chiorini, J, Davidson, B and McWhir, J (2003). Infection efficiency of human and mouse embryonic stem cells using adenoviral and adeno-associated viral vectors. Cloning Stem Cells 5: 51-62.
40. Ma, Y, Ramezani, A, Lewis, R, Hawley, RG and Thomson, JA (2003). High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 21: 111-117.
41. Moore, JC, van Laake, LW, Braam, SR, Xue, T, Tsang, SY, Ward, D et al. (2005). Human embryonic stem cells: Genetic manipulation on the way to cardiac cell therapies. Reprod Toxicol 20: 377-391.
42. Xiong, C, Tang, DQ, Xie, CQ, Zhang, L, Xu, KF, Thompson, WE et al. (2005). Genetic engineering of human embryonic stem cells with lentiviral vectors. Stem Cells Dev 14: 367-377.
43. Xue, T, Cho, HC, Akar, FG, Tsang, SY, Jones, SP, Marban, E et al. (2005). Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardioomyocytes: Insights into the development of cell-based pacemakers. Circulation 111: 11-20.
44. Pfeifer, A, Ikawa, M, Dayn, Y and Verma, IM (2002). Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci USA 99 2140-2145.
45. Gropp, M, Itsykson, P, Singer, O, Ben-Hur, T, Reinhartz, E, Galun, E et al. (2003). Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol Ther 7: 291-287.
46. Jang, JE, Shaw, K, Yu, XJ, Petersen, D, Pepper, K, Lutzko, C et al. (2006). Specific and stable gene transfer to human embryonic stem cells using pseudotyped lentiviral vectors. Stem Cells Dev 15 109-117.
47. Artelt P, Grannemann, R, Stocking, C, Friel, J, Bartsch, J and Hauser, H (1991). The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells. Gene 99: 249-254.
48. Bayever, E, Haines, K, Duprey, S, Rappaport, E, Douglas, SD and Surrey, S (1988). Protection of uninfected human bone marrow cells in long-term culture from G418 toxicity after retroviral-mediated transfer of the NEOr gene. Exp Cell Res 179: 168-180.
49. Hlavaty, J, Portsmouth, D, Stracke, A, Salmons, B, Gunzburg, WH and Renner, M (2004). Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors. Virology 330 351-360.
50. Spencer, DM (2000). Developments in suicide genes for preclinical and clinical applications. Curr Opin Mol Ther 2: 433-440.
51. Yao, S, Sukonnik, T, Kean, T, Bharadwaj RR, Pasceri, P and Ellis, J (2004). Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. Mol Ther 10: 27-36.
52. Mavilio, F, Ferrari, G, Rossini, S, Nobili, N, Bonini, C, Casorati, G et al. (1994). Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83: 1988-1997.
53. Orchard, PJ, Blazar, BR, Burger, S, Levine, B, Basso, L, Nelson, DM et al. (2002). Clinical-scale selection of anti-CD3/CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex vinis thymidine kinase and truncated nerve growth factor receptor. Hum Gene Ther 13: 979-988.
54. Bonini, C, Grez, M, Traversari, C, Ciceri, F, Marktel, S, Ferrari, G et al. (2003). Safety of retroviral gene marking with a truncated NGF receptor. Nat Med 9: 367-369.
55. Bjorklund, LM, Sanchez-Pernaute, R, Chung, S, Andersson, T, Chen, IY, McNaught, KS et al. (2002). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99: 2344-2349.
56. Robinson, AJ, Meedeniya, AC, Hemsley, KM, Auclair, D, Crawley, AC and Hopwood, JJ (2005). Survival and engraftment of mouse embryonic stem cell-derived implants in the guinea pig brain. Neurosci Res 53 161-168.
57. Bonini, C, Ferrari, G, Verzeletti, S, Servida, P, Zappone, E, Ruggleri, L et al. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276: 1719-1724.
58. Tiberghien, P, Ferrand, C, Licure, B, Milpied, N, Angonin, R, Deconinck, E et al. (2001). Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 97: 63-72.
59. Fillat, C, Carrio, M, Cascante, A and Sangro, B (2003). Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/ Ganciclovir system: Fifteen years of application. Curr Gene Ther 3: 13-26.
60. Schuldiner, M, Itskovitz-Eldor, J and Benvenisty, N (2003). Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 21: 257-265.
61. Tabar, V, Panagiotakos, G, Greenberg, ED, Chan, BK, Sadelain, M, Gutin, PH et al. (2005). Migration and differentiation of neural precursors derived from human embryonic stem cells in the rat brain. Nat Biotechnol 23: 601-606.
62. Roy, NS, Cleren, C, Singh, SK, Yang, L, Beal, MF and Goldman, SA (2006). Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12: 1259-1268.
63. Keller, G (2005). Embryonic stem cell differentiation: Emergence of a new era in biology and medicine. Genes Dev 19: 1129-1155.
64. Tevethia, MJ (1984). Immortalization of primary mouse embryo fibroblasts with SV40 virions, viral DNA, and a subgenomic DNA fragment in a quantitative assay. Virology 137: 414-421.
65. Malyankar, UM, Rittling, SR and Denhardt, DT (1996). Instability of endogenous MRP/proliferin transcripts in the nucleus of mouse embryo fibroblasts contrasts with their stability when produced during transient transfections. J Cell Biochem 60: 198-210.
66. Yang, X, Sham, JS, Ng, MH, Tsao, SW, Zhang, D, Lowe, SW et al. (2000). LMP1 of Epstein-Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatively transforms the cells with a p16-insensitive CDK4 oncogene. J Virol 74: 883-891.
67. Ruscoe, JE, Rosario, LA, Wang, T, Gate, L, Arifoglu, P, Wolf, CR et al. (2001). Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmocal Exp Ther 298: 339-345.
68. Oh, MK, Scoles, DR, Haipek, C, Strand, AD, Gutmann, DH, Olson, JM et al. (2003). Genetic heterogeneity of stably transfected cell lines revealed by expression profiling with oligonucleotide microarrays. J Cell Biochem 90: 1068-1078.
69. Akita, S, Daian, T, Ishihara, H, Fujii, T and Akino, K (2004). Leukemia inhibitory factor-transfected embryonic fibroblasts and vascular enothelial growth factor successfully improve the skin substitute wound healing by increasing angiogenesis and matrix production. J Dermatol Sci 36: 11-23.
70. im, TI, Sea, HJ, Choi, JS, Yoon, JK, Baek, JU, Kim, K et al. (2005). Synthesis of biodegradable cross-linked poly(beta-amino ester) for gene delivery and its modification, inducing enhanced transfection efficiency and stepwise degradation. Bioconjug Chem 16: 1140-1148.
71. Schwenter, F, Deglon, N and Aebischer, P (2003). Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapy. J Gene Med b 5: 246-257.
72. Shapiro, GS, Van Peursem, C, Omelles, DA, Schaack, J and DeGregori, J (2006). Recombinant adenoviral vectors can induce expression of p73 via the E4-orf6/7 protein. J Virol 80: 5349-5360.
73. Spector, DH, Wade, E, Wright, DA, Koval, V, Clark, C, Jaquish, D et al. (1990). Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J Virol 64: 2298-2308.
74. Xu, C, Jiang, J, Sottile, V, McWhir, J, Lebkowski, J and Carpenter, MK (2004). Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells 22 972-980.
75. Zeng, XR, Sun, Y, Wenger, L and Cheung, HS (2005). Basic calcium phosphate crystal-induced Egr-1 expression stimulates mitogenesis in human fibroblasts. Biochem Biophys Res Commun 330: 658-664.
76. + hematopoiesis in vitro. Stem Cells Dev 14: 505-516.
77. Wolins, NE, Quaynor, BK, Skinner, JR, Tzekov A, Park, C, Choi, K et al. (2006). OP9 mouse stromal cells rapidly differentiate into adipocytes: Characterization of a useful new model of adipogenesis. J Lipid Res 47: 450-460.
78. Mizuguchi, H, Xu, Z, Ishii-Watabe, A, Uchida, E and Hayakawa, T (2000). IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1: 376-382.
79. Hemminki, A, Belousova, N, Zinn, KR, Liu, B, Wang, M, Chaudhuri, TR et al. (2001). An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression. Mol Ther 4: 223-231.
80. Sasaki, S, Takeshita, F, Oikawa, T, Kojima, Y, Xin, KQ, Okuda, K et al. (2004). Improvement of DNA vaccine immunogenicity by a dual antigen expression system. Biochem Biophys Res Commun 315: 38-43.
81. Belousova, N, Harris, R, Zinn, K, Rhodes-Selser, MA, Kotav, A, Kotova, O et al. (2006). Circumventing recombination events encountered with production of a clinical-grade adenoviral vector with a double-expression cassette. Mol Pharmacol 70: 1488-1493.
82. Fang, J, Qian, JJ, Yi, S, Harding, TC, Tu, GH, VanRoey, M et al. (2005). Stable antibody expression at therapeutic levels using the 2A peptide. Nat Biotechnol 23: 584-590.
83. Baum, C, Dullmann, J, Li, Z, Fehse, B, Meyer, J, Williams, DA et al. (2003). Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101: 2099-2114.
84. Ferguson, C, Larochelle, A and Dunbar, CE (2005). Hematopoietic stem cell gene therapy: Dead or alive? Trends Biotechnol 23: 589-597.
85. Hendrie, PC and Russell, DW (2005). Gene targeting with viral vectors. Mol Ther 12: 9-17.
86. Sinn, PL, Sauter, SL and McCray, PB Jr. (2005). Gene therapy progress and prospects: Development of improved lentiviral and retroviral vectors - design, biosafety, and production. Gene Ther 12: 1089-1098.
87. Amit, M, Carpenter, MK, Inokuma, MS, Chiu, CP, Harris, CP, Waknitz, MA et al. (2000). Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227: 271-278.
88. Heins, N, Lindahl, A, Karlsson, U, Rehnstrom, M, Caisander, G, Emanuelsson, K et al. (2006). Clonal derivation and characterization of human embryonic stem cell lines. J Biotechnol 122: 511-520.
89. Heins, N, Englund, MC, Sjoblom, C, Dahl, U, Tonning, A, Bergh, C et al. (2004). Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells 22: 367-376.
90. Papadakis, ED, Nicklin, SA, Baker, AH and White, SJ (2004). Promoters and control elements: Designing expression cassettes for gene therapy. Curr Gene Ther 4: 89-113.
91. Lewandoski, M (2001). Conditional control of gene expression in the mouse. Nat Rev Genet 2: 743-755.
92. Weber, W and Fussenegger, M (2006). Pharmacologic transgene control systems for gene therapy. J Gene Med 8: 535-556.
93. Hurley, CK (2002). HLA diversity: Detection and impact on unrelated hematopoietic stem cell donor characterization and selection. Int J Hematol 76 (suppl. 2): 152-154.
94. Sheldon, S and Poulton, K (2006). HLA typing and its influence on organ transplantation. Methods Mol Biol 333: 157-174.
95. Sonnenberg, FA, Eckman, MH and Pauker, SG (1989). Bone marrow donor registries: The relation between registry size and probability of finding complete and partial matches. Blood 74: 2569-2578.
96. Cowan, CA, Atienza, J, Melton, DA and Eggan, K (2005). Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309: 1369-1373.
97. Jenuwein, T (2006). The epigenetic magic of histone lysine methylation. FEBS J 273: 3121-3135.
98. Tada, M, Takahama, Y, Abe, K, Nakatsuji, N and Tada, T (2001). Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11: 1553-1558.
99. Verlinsky, Y, Strelchenko, N, Kukharenko, V, Shkumatov, A, Rechitsky, S, Verlinsky, O et al. (2006). Repository of human embryonic stem cell lines and development of individual specific lines using stembrid technology. Reprod Biomed Online 13: 547-550.
100. Alan, JS (1996). Xenotransplantation at a crossroads: Prevention versus progress. Nat Med 2: 18-21.
101. Ellerstrom, C, Strehl, R, Moya, K, Andersson, K, Bergh, C, Lundin, K et al. (2006). Derivation of a xeno-free human embryonic stem cell line. Stem Cells 24: 2170-2176.
102. Ludwig, TE, Levenstein, ME, Jones, JM, Berggren, WT, Mitchen, ER, Frane, JL et al. (2006). Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24: 185-187.
103. Cowan, CA, Klimanskaya, I, McMahon, J, Atienza, J, Witmyer, J, Zucker, JP et al. (2004). Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350: 1353-1356.
104. Draper, JS, Smith, K, Gokhale, P, Moore, HD, Maltby, E, Johnson, J et al. (2004). Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22: 53-54.
105. Draper, JS, Moore, HD, Ruban, LN, Gokhale, PJ and Andrews, PW (2004). Culture and characterization of human embryonic stem cells. Stem Cells Dev 13: 325-336.
106. Aberdam, D (2004). Derivation of keratinocyte progenitor cells and skin formation from embryonic stem cells. Int J Dev Biol 48: 203-206.
107. Coraux, C, Nawrocki-Raby, B, Hinnrasky, J, Kileztky, C, Gaillard, D, Dani, C et al. (2005). Embryonic stem cells generate airway epithelial tissue. Am J Respir Cell Mol Biol 32: 87-92.
108. Yamamoto, K, Sokabe, T, Watabe, T, Miyazono, K, Yamashita, JK, Obi, S et al. (2005). Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro. Am J Physiol Heart Circ Physiol 288: H-1915-H1924.
109. + progenitors differentiate into smooth muscle cells, which is mediated by collagen IV-integrin alpha1/beta1/alphav and PDGF receptor pathways. Am J Physiol Cell Physiol 292: C342-C352.
110. Yang, W, Gomes, RR, Brown, AJ, Burdett, AR, Alicknavitch, M, Farach-Carson, MC et al. (2006). Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices. Tissue Eng 12: 2009-2024.
111. Moore, KA and Lemischka, IR (2006). Stem cells and their niches. Science 311: 1880-1885.
112. Tavassoli, M and Hardy, CL (1990). Molecular basis of homing of intravenously transplanted stem cells to the marrow. Blood 76 1059-1070.
113. Overturf, K, Al-Dhalimy, M, Tanguay, R, Brantly, M, Ou, CN, Finegold, M et al. (1996). Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet 12: 266-273.
114. Blanpain, C, Lowry, WE, Geoghegan, A, Polak L and Fuchs, E (2004). Self-renewal, multipotency,and the existence of two cell populations within an epithelial stem cell niche. Cell 118: 635-648.
115. Morris, RJ, Liu, Y, Marles, L, Yang, Z, Trempus, C, Li, S et al. (2004). Capturing and profiling adult hair follicle stem cells. Nat Biotechnol 22: 411-417.
116. Shapiro, AM, Lakey, JR, Ryan, EA, Korbutt, GS, Toth, E, Warnock, GL et al. (2000). Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230-238.
117. Lakey, JR, Mirbolooki, M and Shapiro, AM (2006). Current status of clinical islet cell transplantation. Methods Mol Biol 333: 47-104.
118. Shapiro, AM, Ricordi, C, Hering, BJ, Auchincloss, H, Lindblad, R, Robertson, RP et al. (2006). International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355: 1318-1330.
119. Lanza, RP, Chung, HY, Yoo, JJ, Wettstein, PJ, Blackwell, C, Borson, N et al. (2002). Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol 20: 689-696.
120. Reubinoff, BE, Pera, MF, Fong, CY, Trounson, A and Bongso, A (2000). Embryonic stem cell lines from human biastocysts: Somatic differentiation in vitro. Nat Biotechnol 18: 399-404.
121. Baharvand, H, Hajheidari, M, Ashtiani, SK and Salekdeh, GH (2006). Proteomic signature of human embryonic stem cells. Proteomics 6 3544-3549.
122. Brandenberger, R, Khrebtukova, I, Thies, RS, Miura, T, Jingli, C, Puri, R et al. (2004). MPSS profiling of human embryonic stem cells. BMC Dev Biol 4: 10.
123. Josephson, R, Sykes, G, Liu, Y, Ording, C, Xu, W, Zeng, X et al. (2006). A molecular scheme for improved characterization of human embryonic stem cell lines. BMC Biol 4: 28.
124. Liu, Y, Shin, S, Zeng, X, Zhan, M, Gonzalez, R, Mueller, FJ et al. (2006). Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev Biol 6 20.
125. Richards, M, Tan, SP, Tan, JH, Chan, WK and Bongso, A (2004). The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22: 51-64.
126. Sato, N, Sinjuan, IM, Heke, M, Uchida, M, Naef, F and Brivanlou, AH (2003). Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev Biol 260: 404-413.
127. Skottman, H, Mikkola, M, Lundin, K, Olsson, C, Stromberg, AM, Tuuri, T et al. (2005). Gene expression signatures of seven individual human embryonic stem cell lines. Stem Cells 23: 1343-1356.
128. Tan, SM and Droge, P (2005). Comparative analysis of sequence-specific DNA recombination systems in human embryonic stem cells. Stem Cells 23: 868-873.
129. Singh, RN, Nakano, T, Xuing, L, Kang, J, Nedergaard, M and Goldman, SA (2005). Enhancer-specified GFP-based FACS purification of human spinal motor neurons from embryonic stem cells. Exp Neurol 196: 224-234.
130. Kim, JH, Do, HJ, Choi, SJ, Cho, HJ, Park, KH, Yang, HM et al. (2005). Efficient gene delivery in differentiated human embryonic stem cells. Exp Mol Med 37: 36-44.
131. Ren, CP, Zhao, M, Shan, WJ, Yang, XY, Yin, ZH, Jiang, XJ et al. (200S). Establishment of human embryonic stem cell line stably expressing Epstein-Barr virus-encoded nuclear antigen 1. Acta Biochim Biophys Sin (Shanghai) 37: 68-73.
132. Lakshmipathy, U, Pelacho, B, Sudo, K, Linehan, JL, Coucouvanis, E, Kaufman, DS et al. (2004). Efficient transfection of embryonic and adult stem cells. Stem Cells 22: 531-543.